What is pathophysiology of Alzheimer?

['Dangalah halaman iko']

Apo pathophysiologi dari alzheimer?

Patofisiologi panyakik Alzheimer (AD) adolah proses kompleks nan maliputi akumulasi protein abnormal, radang, jo disfungsi neuronal.

Kaduo ciri utamo panyakik Alzheimer adolah adonyo plak amiloid-beta (Aβ) jo neurokabel (NFT) di utak.

Plak amiloid-beta tabantuak katiko pacahan protein pendahulu amiloid (APP) dipacah dek enzim untuak mambantuak peptida Aβ.

Peptida iko mangumpua jo mambantuak fibril nan indak laruik nan mangumpuakan di lua neuron, mangacaukan komunikasi sel-sel jo manyababkan kamatian neuron.

Akumulasi plak Aβ dianggap sabagai salah satu kajadian nan paliang awa dalam parkambangan AD, dan diyakini dapek manyumbang pado proses neurodegeneratif.

Tali-tali neurofibrillary tabantuak katiko protein tau manjadi hiperfosforilasi jo mambantuak filamen abnormal di dalam neuron.

Tali-tali iko mangacaukan fungsi normal mikrotubulus, nan pantiang untuak transportasi nutrisi jo bahan lain di dalam neuron.

Pangkaik-angkaik akhianyo manyababan kamatian neuron nan taserak.

Radang juo baparan dalam patofisiologi AD.

Sistem kakebalan mananggapi akumulasi plak Aβ jo NFT jo malapehan sitokin pro-inflamasi, nan dapek maningkekan karusakan neuron.

Salain itu, ado bukti baso stres oksidatif, disfungsi mitokondria, jo gangguan metabolisme glukosa dapek manyababkan panyakik Alzheimer.

Faktor-faktor iko dapek manyababkan disfungsi jo kamatian neuron, nan labiah maningkekkan panyakik.

Sacaro kasaluruahan, patofisiologi AD adolah interaksi kompleks dari babagai faktor nan akhianyo manyababan panurunan progresif fungsi kognitif jo hilangnyo ingatan nan manjadi ciri panyakik ko.

['Rujuakan']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Nemeroff CB: The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine. Arch Gen Psychiatry. 1999, 56 (11): 991-2.

Skoog I, Kalaria RN, Breteler MM: Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord. , 13 Suppl 3 (): S106-14.

Proft J, Weiss N: Jekyll and Hide: The two faces of amyloid β. Commun Integr Biol. 2012, 5 (5): 405-7.

Whitehouse PJ, Hedreen JC, White CL, Price DL: Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol. 1983, 13 (3): 243-8.

Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA, Perry G: Indices of metabolic dysfunction and oxidative stress. Neurochem Res. , 32 (4-5): 717-22.

Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicanò M, Rizzo C, Scapagnini G, Vasto S: Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res. , 13 (2-3): 301-13.

Raskind MA, Peskind ER: Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994, 8 Suppl 3 (): 54-60.

Schindler SE, McConathy J, Ances BM, Diamond MI: Advances in diagnostic testing for Alzheimer disease. Mo Med. , 110 (5): 401-5.

Singh VK: Immune-activation model in Alzheimer disease. Mol Chem Neuropathol. , 28 (1-3): 105-11.

['Disclaimer: medis']

['Situs web iko hanyo digunokan untuak tujuan pandidikan jo informasi sajo dan indak mambari nasehat medis atau layanan profesional.']

['Informasi nan disadioan indak buliah digunoan untuak mandiagnosis atau maubek masalah kasihatan atau panyakik, dan urang nan mancari nasehat medis pribadi harus bakonsultasi jo dotor nan balisensi.']

['Tolong diingek jaringan saraf nan manghasilkan jawaban untuak pertanyaan, khususnyo indak akurat katiko datang ka isi numerik. contohnyo, jumlah urang nan didiagnosis jo panyakik tatantu.']

['Salalu mintak nasehat dotor atau panyadia kasihatan lain nan kualifikasi manganai kondisi medis. Jan pernah maabaikan nasehat medis profesional atau talambek dalam mamintaknyo dek karano sasuatu nan awak baco di situs web iko. Jiko awak sangko mungkin ado kaadaan darurat medis, hubungi 911 atau pai ka ruang gawat darurat paliang dakek lansuang. Indak ado hubungan dotor-pasien nan diciptaan dek situs web iko atau panggunoannyo. BioMedLib maupun karyawan, maupun kontributor situs web iko, indak ado malakukan representasi, jaleh atau tasuruak, manganai informasi nan disadioan di siko atau panggunoannyo.']

['Panyalasaian: hak cipta']

['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (DMCA) manyadiokan jalan bagi pamilik hak cipta nan picayo bahwasanyo bahan nan muncul di Internet malangga haknyo manuruik hukum hak cipta AS. ']

['Jiko Sanak yakin jo yakin baso isi atau bahan nan tasadio dalam pautan ka situs web atau layanan kami malangga hak cipta Sanak, Sanak (atau agen Sanak) dapek mangirim kami pasan mamintak untuak manghapuih isi atau bahan tasabuik, atau mamblokir akses ka situs tasabuik. ']

['Kabar harus dikirim sacaro tulisan malalui surel (caliak bagian "Kontak" untuak alamat surel).']

['DMCA mamaraluan supayo pasan pasan palanggaran hak cipta nan didakwa tamasuak informasi barikuik: (1) deskripsi karya hak cipta nan manjadi subyek palanggaran nan didakwa; (2) deskripsi isi nan didakwa malanggar jo informasi nan cukuik untuak mamungkinkan kami untuak manamukan isi; (3) informasi kontak untuak Sanak, tamasuak alamat, nomor telepon jo alamat surel; (4) pernyataan Sanak baso Sanak punyo kayakinan baiak baso isi nan dikaduan indak diizinkan dek nan punyo hak cipta, atau agennyo, atau dek operasi hukum apo pun; ']

['(5) suatu pernyataan nan ditandotangani dek Sanak, jo hukuman sumpah palsu, baso informasi dalam notifikasi tu akurat jo Sanak punyo wewenang untuak manjalankan hak cipta nan dikatokan alah di langgar; ']

['dan (6) ciek tando tangan fisik atau elektronik dari pamilik hak cipta atau sasaurang nan punyo hak untuak batindak ateh namo pamilik hak cipta. ']

['Kok indak tamasuak sado informasi di ateh dapek manyababkan panundaan pangolahan aduan Sanak.']

['Kontak']

['Tolong kirim surel untuak pertanyaan/saran.']

What is pathophysiology of alzheimer?

The pathophysiology of Alzheimer's disease (AD) is a complex process that involves the accumulation of abnormal proteins, inflammation, and neuronal dysfunction.

The two main hallmarks of AD are the presence of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain.

Amyloid-beta plaques are formed when fragments of the amyloid precursor protein (APP) are cleaved by enzymes to form Aβ peptides.

These peptides aggregate and form insoluble fibrils that accumulate outside neurons, disrupting cell-to-cell communication and leading to neuronal death.

The accumulation of Aβ plaques is thought to be one of the earliest events in the development of AD, and it is believed to contribute to the neurodegenerative process.

Neurofibrillary tangles are formed when the protein tau becomes hyperphosphorylated and forms abnormal filaments inside neurons.

These tangles disrupt the normal functioning of the microtubules, which are essential for the transport of nutrients and other materials within the neuron.

The tangles eventually lead to the death of the affected neurons.

Inflammation also plays a role in the pathophysiology of AD.

The immune system responds to the accumulation of Aβ plaques and NFTs by releasing pro-inflammatory cytokines, which can exacerbate the damage to neurons.

Additionally, there is evidence that oxidative stress, mitochondrial dysfunction, and impaired glucose metabolism contribute to the pathophysiology of AD.

These factors can lead to neuronal dysfunction and death, further exacerbating the disease process.

Overall, the pathophysiology of AD is a complex interplay of multiple factors that ultimately lead to the progressive decline in cognitive function and memory loss that characterizes the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.